Haemonetics Stock Options Expiring on 17th of January 2025
| HAE Stock | USD 75.08 0.41 0.54% |
Haemonetics' latest option contracts expiring on 2025-01-17 have a put-to-call open interest ratio of 0.53 over 40 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2025-01-17. The Haemonetics option chain provides detailed quote and price information for the current Haemonetics option contracts. It shows all of Haemonetics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2025-01-17 Option Contracts
2025-01-17
The chart above shows Haemonetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Haemonetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Haemonetics' option, there is no secondary market available for investors to trade.
Haemonetics Maximum Pain Price across 2025-01-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Haemonetics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Haemonetics' stock options are financial instruments that give investors the right to buy or sell shares of Haemonetics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Haemonetics stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Haemonetics' stock price goes up or down, the stock options follow.
At present, Haemonetics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. Haemonetics In The Money Call Balance
When Haemonetics' strike price is surpassing the current stock price, the option contract against Haemonetics stock is said to be in the money. When it comes to buying Haemonetics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Haemonetics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Haemonetics Current Options Market Mood
Haemonetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Haemonetics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Haemonetics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Haemonetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Haemonetics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Haemonetics contract
Base on the Rule 16, the options market is currently suggesting that Haemonetics will have an average daily up or down price movement of about 0.0% per day over the life of the 2025-01-17 option contract. With Haemonetics trading at USD 75.08, that is roughly USD 0.0. If you think that the market is fully incorporating Haemonetics' daily price movement you should consider buying Haemonetics options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Haemonetics |
Haemonetics Option Chain
When Haemonetics' strike price is surpassing the current stock price, the option contract against Haemonetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Haemonetics' option chain is a display of a range of information that helps investors for ways to trade options on Haemonetics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Haemonetics. It also shows strike prices and maturity days for a Haemonetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2025-01-17 CALL at $40.0 | 0.9902 | 0.0012 | 0 | 2025-01-17 | 33.5 - 38.0 | 0.0 | In |
Call | 2025-01-17 CALL at $45.0 | 0.963 | 0.0033 | 0 | 2025-01-17 | 29.0 - 33.3 | 0.0 | In |
Call | 2025-01-17 CALL at $50.0 | 0.9695 | 0.0038 | 3 | 2025-01-17 | 23.9 - 28.2 | 27.0 | In |
Call | 2025-01-17 CALL at $55.0 | 0.907 | 0.0081 | 0 | 2025-01-17 | 20.3 - 23.5 | 0.0 | In |
Call | 2025-01-17 CALL at $60.0 | 0.9154 | 0.0111 | 0 | 2025-01-17 | 15.1 - 18.0 | 0.0 | In |
Call | 2025-01-17 CALL at $65.0 | 0.8364 | 0.0184 | 0 | 2025-01-17 | 10.8 - 13.8 | 0.0 | In |
Call | 2025-01-17 CALL at $70.0 | 0.7058 | 0.0241 | 0 | 2025-01-17 | 8.7 - 9.4 | 0.0 | In |
Call | 2025-01-17 CALL at $75.0 | 0.5708 | 0.0291 | 0 | 2025-01-17 | 5.6 - 6.3 | 0.0 | In |
Call | 2025-01-17 CALL at $80.0 | 0.3982 | 0.035 | 2 | 2025-01-17 | 1.75 - 4.0 | 5.0 | Out |
Call | 2025-01-17 CALL at $85.0 | 0.2659 | 0.0281 | 12 | 2025-01-17 | 1.0 - 2.5 | 2.2 | Out |
Call | 2025-01-17 CALL at $90.0 | 0.2106 | 0.0207 | 51 | 2025-01-17 | 1.0 - 2.05 | 1.51 | Out |
Call | 2025-01-17 CALL at $95.0 | 0.1526 | 0.016 | 13 | 2025-01-17 | 0.35 - 1.8 | 1.1 | Out |
Call | 2025-01-17 CALL at $100.0 | 0.0872 | 0.0113 | 59 | 2025-01-17 | 0.15 - 0.9 | 1.51 | Out |
Call | 2025-01-17 CALL at $105.0 | 0.113 | 0.0106 | 22 | 2025-01-17 | 0.1 - 1.7 | 2.95 | Out |
Call | 2025-01-17 CALL at $110.0 | 0.0993 | 0.009 | 13 | 2025-01-17 | 0.05 - 1.6 | 2.3 | Out |
Put | 2025-01-17 PUT at $50.0 | -0.0714 | 0.0057 | 0 | 2025-01-17 | 0.1 - 1.65 | 0.0 | Out |
Put | 2025-01-17 PUT at $55.0 | -0.0674 | 0.0074 | 4 | 2025-01-17 | 0.35 - 0.8 | 0.75 | Out |
Put | 2025-01-17 PUT at $60.0 | -0.1361 | 0.012 | 45 | 2025-01-17 | 0.6 - 2.2 | 1.0 | Out |
Put | 2025-01-17 PUT at $65.0 | -0.199 | 0.018 | 9 | 2025-01-17 | 1.35 - 2.55 | 2.15 | Out |
Put | 2025-01-17 PUT at $70.0 | -0.3163 | 0.0216 | 1 | 2025-01-17 | 2.65 - 5.0 | 3.2 | Out |
Put | 2025-01-17 PUT at $75.0 | -0.4397 | 0.0295 | 6 | 2025-01-17 | 4.6 - 5.2 | 5.3 | Out |
Put | 2025-01-17 PUT at $80.0 | -0.5905 | 0.0297 | 2 | 2025-01-17 | 7.3 - 8.2 | 7.9 | In |
Put | 2025-01-17 PUT at $85.0 | -0.7418 | 0.0266 | 11 | 2025-01-17 | 10.6 - 11.6 | 6.5 | In |
Put | 2025-01-17 PUT at $90.0 | -0.8022 | 0.0195 | 36 | 2025-01-17 | 14.2 - 17.5 | 8.2 | In |
Put | 2025-01-17 PUT at $95.0 | -0.9637 | 0.0064 | 0 | 2025-01-17 | 17.9 - 22.0 | 20.5 | In |
Put | 2025-01-17 PUT at $100.0 | -0.9266 | 0.009 | 0 | 2025-01-17 | 23.1 - 27.1 | 14.7 | In |
Put | 2025-01-17 PUT at $105.0 | -0.9604 | 0.0049 | 0 | 2025-01-17 | 27.9 - 32.1 | 0.0 | In |
Put | 2025-01-17 PUT at $110.0 | -0.9629 | 0.0042 | 0 | 2025-01-17 | 32.9 - 37.1 | 0.0 | In |
Put | 2025-01-17 PUT at $115.0 | -0.9647 | 0.0037 | 0 | 2025-01-17 | 37.9 - 42.1 | 0.0 | In |
Put | 2025-01-17 PUT at $120.0 | -0.9662 | 0.0033 | 0 | 2025-01-17 | 42.9 - 47.1 | 0.0 | In |
Put | 2025-01-17 PUT at $125.0 | -0.8108 | 0.0079 | 0 | 2025-01-17 | 47.6 - 52.1 | 0.0 | In |
Put | 2025-01-17 PUT at $130.0 | -0.8233 | 0.0074 | 0 | 2025-01-17 | 52.9 - 56.9 | 0.0 | In |
Put | 2025-01-17 PUT at $135.0 | -0.9691 | 0.0026 | 0 | 2025-01-17 | 57.9 - 62.1 | 0.0 | In |
Haemonetics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Haemonetics Total Stockholder Equity
Total Stockholder Equity |
|
Haemonetics Corporate Directors
| Robert Abernathy | Independent Director | Profile | |
| Claire Pomeroy | Independent Director | Profile | |
| Catherine Burzik | Independent Director | Profile | |
| Mark Kroll | Independent Director | Profile |
Additional Information and Resources on Investing in Haemonetics Stock
When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haemonetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Earnings Share 2.23 | Revenue Per Share 26.255 | Quarterly Revenue Growth 0.08 | Return On Assets 0.0609 |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.